Country
Ireland
Ireland-based Neurent Medical Ltd has raised $25 million in Series B financing to prepare its lead product for chronic rhinitis for a regulatory application and commercialisation in the US.
Full text available to subscribers only. Click here for information on subscribing to MedNous.